Corrigendum: Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR

Front Pharmacol. 2018 Oct 9:9:1128. doi: 10.3389/fphar.2018.01128. eCollection 2018.

Authors

Affiliation

¹ Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2018.01016.].

Keywords: MAPKs; NF-kB; RANKL; osteoclast; osteoporosis; uPAR; ulinastatin.

Publication types

Published Erratum